|
Bradley Anderson,
Ph.D. AWARDS, FELLOWSHIPS, EXTRAMURAL GRANTS 1999-2000, in review: NIH RFA Application; CNS Drug Delivery Strategies Targeting the HIV Sanctuary; B.D. Anderson, PI; $1,675,920 (direct costs). 1998-2000, $145,927: Pfizer Inc., Controlling Oxidation in Formulations - Studies of Model Drug Oxidation in Solution and in the Amorphous Solid State; B.D. Anderson, PI; $122,816 (direct costs). 1997-2002, $1,373,694: NCI/NIH Contract; Development of Dosage Forms and Delivery Systems for Antitumor and Anti-AIDS Agents; B.D. Anderson, PI; $918,859 (direct costs). 1997, $19,508: PRAECIS Pharmaceuticals Inc.; Characterization of PPI-149 Depot: Preliminary Assessment; B.D. Anderson, PI. 1997, $4,988: PRAECIS Pharmaceuticals Inc.: Characterization of PPI-149 Depot: Preliminary Assessment; B.D. Anderson, PI. 1996, $45,478: University of Utah Research Instrumentation Fund; High Performance Capillary Electrophoresis System; B.D. Anderson, PI. 1996-99, $897,290: NIH Grant 1 RO1 GM51347-01A2; Permeabilities in Lipid Bilayer Membranes; B.D. Anderson, PI. 1996, $10,000: Theratech Inc.; unrestricted grant; B.D. Anderson, PI.
|
||
|
Room 327-G Pharmaceutical Sciences - Rose Street, Lexington, KY 40536-0082 - Phone (859) 257-7896 - Fax (859) 323-0242 |
||
|
Comments to
J. Carol Guinnup, Last
Modified: July 21, 2000
|